The Brenden-Colson Center for Pancreatic Care is a patient-focused clinical and scientific research center dedicated to easing the burden of pancreatic disease. We concentrate our efforts on three critical areas:

• Earlier Detection: Finding pancreatic disease sooner so that treatment can begin quickly.
• Advanced Therapy: Developing new and effective treatment choices.
• Patient Resilience: Discovering ways to help patients maintain their overall well-being throughout their journey.

Our program is built on teamwork, with program leaders working closely together to enhance results. Think of it as a “center without walls,” where doctors caring for patients and scientists in the lab can easily share information and ideas. This collaboration connects patient care directly with research discoveries.

The Center is led by Co-Directors Brett C. Sheppard, M.D. , and Rosalie C. Sears, Ph.D. , along with Deputy Director Jonathan Brody, Ph.D. Dr. Sheppard contributes expertise in surgery and education, while Dr. Sears leads laboratory research and partnerships in close collaboration with Dr. Brody. OHSU investigators head teams focused on detecting pancreatic disease earlier and advancing new treatments through clinical trials. Our researchers continually seek new ways to improve patients’ quality of life.

Building on this strong base, we are striving to grow our network. This includes working with more doctors, researchers, partners, and patients. Together we can make significant progress in improving care for people with pancreatic disease.